Wolfrum, P.; Böhm, E.W.; Lorenz, K.; Stoffelns, B.; Pfeiffer, N.; Korb, C.A.
Clinical Outcomes Following a Switch of Therapy to Faricimab in Patients Affected by Neovascular Age-Related Macular Degeneration. J. Clin. Med. 2025, 14, 423.
https://doi.org/10.3390/jcm14020423
AMA Style
Wolfrum P, Böhm EW, Lorenz K, Stoffelns B, Pfeiffer N, Korb CA.
Clinical Outcomes Following a Switch of Therapy to Faricimab in Patients Affected by Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine. 2025; 14(2):423.
https://doi.org/10.3390/jcm14020423
Chicago/Turabian Style
Wolfrum, Peter, Elsa Wilma Böhm, Katrin Lorenz, Bernhard Stoffelns, Norbert Pfeiffer, and Christina A. Korb.
2025. "Clinical Outcomes Following a Switch of Therapy to Faricimab in Patients Affected by Neovascular Age-Related Macular Degeneration" Journal of Clinical Medicine 14, no. 2: 423.
https://doi.org/10.3390/jcm14020423
APA Style
Wolfrum, P., Böhm, E. W., Lorenz, K., Stoffelns, B., Pfeiffer, N., & Korb, C. A.
(2025). Clinical Outcomes Following a Switch of Therapy to Faricimab in Patients Affected by Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine, 14(2), 423.
https://doi.org/10.3390/jcm14020423
